Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory to Chemotherapy”

347 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 347 results

Testing effectiveness (Phase 2)UnknownNCT00006114
What this trial is testing

Combination Chemotherapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

Who this might be right for
Prostate Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group
Testing effectiveness (Phase 2)Looking for participantsNCT06971614
What this trial is testing

T3011 in Patients With BCG-Unresponsive NMIBC or BCG-Exposed, Chemotherapy-Unresponsive NMIBC

Who this might be right for
Nonmuscle-invasive Bladder Cancer
ImmVira Pharma Co. Ltd 160
Early research (Phase 1)Study completedNCT00027898
What this trial is testing

Bortezomib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 27
Testing effectiveness (Phase 2)Study completedNCT00895310
What this trial is testing

Use of Low Dose Ketoconazole in Prostate Cancer That Does Not Respond to Hormone Therapy and Prior Chemotherapy

Who this might be right for
Prostate Cancer
University of California, Davis 30
Post-approval studies (Phase 4)Not Yet RecruitingNCT07288528
What this trial is testing

A 2x2 Factorial, Randomized, Open-label Trial to Evaluate Neuromodulators and Cough Control Therapy in Patients With Refractory or Unexplained Chronic Cough

Who this might be right for
CoughRefractory Chronic CoughUnexplained Chronic Cough+2 more
McMaster University 124
Early research (Phase 1)Study completedNCT02222688
What this trial is testing

UC-961 (Cirmtuzumab) in Relapsed or Refractory Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
Thomas Kipps 26
Testing effectiveness (Phase 2)Study completedNCT00083720
What this trial is testing

Erbitux (Cetuximab) Given Alone to Patients With EGFR-Negative Metastatic Colon or Rectal Cancer That is Refractory to Chemotherapy

Who this might be right for
Colorectal NeoplasmsMetastasesNeoplasm
Eli Lilly and Company 87
Testing effectiveness (Phase 2)Study completedNCT03439280
What this trial is testing

Investigate the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of TAK-079 Administered Subcutaneously as a Single Agent in Participants With Relapsed/Refractory (r/r) Multiple Myeloma (MM)

Who this might be right for
Relapsed/RefractoryMultiple Myeloma
Millennium Pharmaceuticals, Inc. 50
Testing effectiveness (Phase 2)UnknownNCT01930864
What this trial is testing

Metformin Plus Irinotecan for Refractory Colorectal Cancer

Who this might be right for
Colorectal NeoplasmsAdenocarcinoma
Barretos Cancer Hospital 41
Large-scale testing (Phase 3)Looking for participantsNCT05281471
What this trial is testing

Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)

Who this might be right for
Platinum-resistant Ovarian CancerPlatinum-refractory Ovarian CancerFallopian Tube Cancer+4 more
Genelux Corporation 186
Testing effectiveness (Phase 2)UnknownNCT04131621
What this trial is testing

Nivolumab/Ipilimumab in Second Line CUP-syndrome

Who this might be right for
Cancer of Unknown Primary Site
University Hospital Heidelberg 194
Testing effectiveness (Phase 2)WithdrawnNCT03166904
What this trial is testing

Phase II Trial of AZD2014 in RICTOR Amplified Solid Cancer Patients Refractory to Standard Chemotherapy

Who this might be right for
Solid Tumor
Samsung Medical Center
Testing effectiveness (Phase 2)Study completedNCT00045136
What this trial is testing

Chemotherapy, Holmium Ho 166 DOTMP, and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Poniard Pharmaceuticals
Large-scale testing (Phase 3)Study completedNCT01607957
What this trial is testing

Study of TAS-102 in Patients With Metastatic Colorectal Cancer Refractory to Standard Chemotherapies

Who this might be right for
Colorectal Cancer
Taiho Oncology, Inc. 800
Testing effectiveness (Phase 2)Study completedNCT02531737
What this trial is testing

Nintedanib (Vargatef®) Plus Docetaxel in Second Line of Treatment in Patients With Lung Cancer

Who this might be right for
Lung Neoplasms
University Hospital, Limoges 59
Testing effectiveness (Phase 2)UnknownNCT04877275
What this trial is testing

ATG-010(Selinexor) in Combination With Chemotherapy in RRMM

Who this might be right for
Multiple Myeloma
Chunyan Sun, MD 50
Early research (Phase 1)Looking for participantsNCT06654037
What this trial is testing

Testing the Addition of an Anti-Cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (5-Fluorouracil) for Metastatic, Refractory Colorectal Cancer

Who this might be right for
Metastatic Microsatellite Stable Colorectal CarcinomaRefractory Microsatellite Stable Colorectal CarcinomaStage IV Colorectal Cancer AJCC v8
National Cancer Institute (NCI) 39
Testing effectiveness (Phase 2)Ended earlyNCT03648372
What this trial is testing

TAK-981 in People With Advanced Solid Tumors or Cancers in the Immune System

Who this might be right for
NeoplasmsLymphomaHematologic Neoplasms
Takeda 109
Testing effectiveness (Phase 2)UnknownNCT01735604
What this trial is testing

Genetically Engineered Lymphocyte Therapy in Treating Patients With Lymphoma That is Resistant or Refractory to Chemotherapy

Who this might be right for
Hematopoietic/Lymphoid CancerAdult Acute Lymphoblastic Leukemia in RemissionB-cell Adult Acute Lymphoblastic Leukemia+20 more
Chinese PLA General Hospital 50
Testing effectiveness (Phase 2)Study completedNCT02113319
What this trial is testing

Study to Assess Dasatinib in Patients With Core Binding Factors Acute Myelogenous Leukemia

Who this might be right for
Acute Myelogenous Leukemia
University Hospital, Angers 27
Next Page